Influence of preoperative intravitreal injection of Ranibizumab on perioperative VRS parameters in patients with PDR

Influence of preoperative intravitreal injection of Ranibizumab on perioperative VRS parameters in patients with PDR

AIM: To discuss the effects of preoperative vitreous cavity injection of ranibizumab on 25G minimally invasive vitreoretinal surgery(VRS)in patients with proliferative diabetic retinopathy(PDR).<p>METHODS: From February 2013 to December 2015, 74 patients with PDR received VRS(82 eyes)were retr...

Full description

Bibliographic Details
Main Authors:	Jun-Xia Lu, Su-Hua Li, Hua Tian
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2017-08-01
Series:	Guoji Yanke Zazhi
Subjects:	proliferative diabetic retinopathy vitreoretinal surgery ranibizumab vitreous resuscitation
Online Access:	http://ies.ijo.cn/cn_publish/2017/8/201708044.pdf

Similar Items

Changes of vitreous cytokine levels in eyes with PDR after intravitreal injection of Ranibizumab or Triamcinolone acetonide
by: Xin-Ting Wang, et al.
Published: (2020-07-01)

Curative effect of intravitreal injection of ranibizumab combined with vitrectomy for PDR
by: Li-Xiao Shang, et al.
Published: (2019-05-01)

Effect of intravitreal injection of Ranibizumab on choroid in patients with severe NPDR with macular edema
by: Fu-Qin Du, et al.
Published: (2017-11-01)

Effect of ranibizumab injection on the surgical outcome and complications of PDR patients before PPV
by: Hai-Tao Hu, et al.
Published: (2019-05-01)

Clinical efficacy and safety of intravitreal injection Ranibizumab assisted 25G+ minimally invasive VRS in the treatment of severe PDR
by: Hui Ren
Published: (2017-08-01)

Effect of ranibizumab on the efficacy of vitrectomy in patients with PDR
by: Xiao Dong
Published: (2019-05-01)

Expression and its clinical significance of RBP4 in vitreous in patients with proliferative diabetic retinopathy
by: Tian-Yue Cao, et al.
Published: (2018-05-01)

Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation
by: Yan PS, et al.
Published: (2016-04-01)

CLINICAL CHARACTERISTICS OF PROLIFERATIVE DIABETIC RETINOPATHY (PDR) PATIENTS WITH VITREOUS HEMORRHAGE AT CIPTO MANGUNKUSUMO HOSPITAL
by: Reyno Satria Ali, et al.
Published: (2023-02-01)

CLINICAL CHARACTERISTICS OF PROLIFERATIVE DIABETIC RETINOPATHY (PDR) PATIENTS WITH VITREOUS HEMORRHAGE AT CIPTO MANGUNKUSUMO HOSPITAL
by: Reyno Satria Ali, et al.
Published: (2023-02-01)

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects
by: Cengiz Alagöz, et al.
Published: (2016-10-01)

Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab
by: Xuting Hu, et al.
Published: (2019-09-01)

Clinical effect of intravitreal injection of Ranibizumab for severe proliferative diabetic retinopathy
by: Yun-Cheng Ma, et al.
Published: (2016-01-01)

Analysis on risk factors of early bleeding after 23G bead resection for PDR
by: Xiang Wang, et al.
Published: (2019-06-01)

Intravitreal Bevacizumab (Avastin) in Treatment of Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy
by: Attaullah Shah Bukhari, et al.
Published: (2018-06-01)

Clinical effect of Ranibizumab combined with PPV on PDR with neovascular glaucoma at early stage
by: Na Lin, et al.
Published: (2018-02-01)

Early versus Late Pars Plana Vitrectomy in Vitreous Hemorrhage: A Systematic Review
by: Filippo Confalonieri, et al.
Published: (2023-10-01)

A Case of Syphilitic Uveitis in Which Vitreous Surgery Was Useful for the Diagnosis and Treatment
by: Takatoshi Kobayashi, et al.
Published: (2017-01-01)

Reasons for the Late Presentation of Diabetic Retinopathy in Saudi Arabia: A Survey of Patients Who Presented with Advanced Proliferative Diabetic Retinopathy to a Tertiary Eye Hospital
by: Al-Shehri AM, et al.
Published: (2022-12-01)

Clinical effects of 23-G micro-invasive with vitrectomy and phacoemulcification for early proliferative diabetic retinopathy and vitreous hemorrhage
by: Hai-Bo Wang, et al.
Published: (2014-04-01)

Efficacy of 25G pars plana vitrectomy with Conbercept intravitreal injection at the end of surgery for early proliferative diabetic retinopathy with vitreous hemorrhage
by: Su Zhang, et al.
Published: (2023-03-01)

Effect and safety of PPV assisted by intravitreal injection of Conbercept in the treatment of PDR combined with vitreous hemorrhage
by: Chun-Shi Li, et al.
Published: (2021-09-01)

Vitreous Substitutes from Bench to the Operating Room in a Translational Approach: Review and Future Endeavors in Vitreoretinal Surgery
by: Filippo Confalonieri, et al.
Published: (2023-02-01)

Results of research of brain-derived neurotrophic factor level (BDNF) in the vitreous body of patients with proliferative diabetic retinopathy
by: A.A. Putienko, et al.
Published: (2016-02-01)

Causes of vitreous haemorrhage in a tertiary hospital in southern Nigeria
by: Otabor-Olubor OJ, et al.
Published: (2021-01-01)

Effect of Intravitreal Conbercept Injection on Complications of Pars Plana Vitrectomy in Patients with Proliferative Diabetic Retinopathy
by: Yuzhi Ding, et al.
Published: (2023-03-01)

Comprehensive assessment of growth factors, inflammatory mediators, and cytokines in vitreous from patients with proliferative diabetic retinopathy
by: Qiao-Yun Gong, et al.
Published: (2022-11-01)

Phacoemulsification of primary cataract by the second stage after vitreoretinal surgery of PDR patients.
by: Karina Igorevna Konovalova, et al.
Published: (2021-01-01)

27G vitrectomy with proliferative membrane cutting <i>in situ</i> for late PDR
by: Ding-Wang Su, et al.
Published: (2018-07-01)

Correlations Between Different Angiogenic and Inflammatory Factors in Vitreous Fluid of Eyes With Proliferative Diabetic Retinopathy
by: Guanrong Wu, et al.
Published: (2021-09-01)

Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis
by: Chen Zou, et al.
Published: (2018-03-01)

Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy
by: Tsubota K, et al.
Published: (2019-06-01)

A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy
by: Chang-Yu Qiu, et al.
Published: (2022-12-01)

Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment
by: Anikó Balogh, et al.
Published: (2020-12-01)

A case of proliferative diabetic retinopathy in which scintillating particles appeared in the intravitreal cavity after laser photocoagulation
by: Ryohsuke Kohmoto, et al.
Published: (2017-12-01)

Proteomic Analyses of Vitreous in Proliferative Diabetic Retinopathy: Prior Studies and Future Outlook
by: Sarah R. Weber, et al.
Published: (2021-05-01)

Eicosanoid Profiles in the Vitreous Humor of Patients with Proliferative Diabetic Retinopathy
by: Albert L Lin, et al.
Published: (2020-10-01)

Vitreous properties in patients with diabetes mellitus and its relationship with proliferative diabetic retinopathy
by: Yi Gong, et al.
Published: (2023-09-01)

Complications analysis on vitrectomy combined with different tampnoades for diabetic vitreous hemorrhage
by: Wen-Yu Fan, et al.
Published: (2015-05-01)

A Case of Proliferative Retinopathy Complicated with Tuberous Sclerosis Treated by Vitreous Surgery
by: Emika Nemoto, et al.
Published: (2016-12-01)